Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission.
about
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?Breast Milk and Solid Food Shaping Intestinal ImmunityAdaptation to Lactose in Lactase Non Persistent People: Effects on Intolerance and the Relationship between Dairy Food Consumption and Evalution of DiseasesGut microbiota-derived short-chain Fatty acids, T cells, and inflammationDietary fiber in irritable bowel syndrome (Review)Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET.Epigenomic regulation of host-microbiota interactions.Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation?Immune modulation by different types of β2→1-fructans is toll-like receptor dependentEpigenomics and the microbiota.Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity.Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome.Immunodeficiency and autoimmune enterocolopathy linked to NFAT5 haploinsufficiencyIntraperitoneal administration of butyrate prevents the severity of acetic acid colitis in ratsColonic butyrate- algesic or analgesic?Faecalibacterium prausnitzii Strain HTF-F and Its Extracellular Polymeric Matrix Attenuate Clinical Parameters in DSS-Induced ColitisEffectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis.Effects of Fuzhuan Brick-Tea Water Extract on Mice Infected with E. coli O157:H7.Dietary Butyrate Helps to Restore the Intestinal Status of a Marine Teleost (Sparus aurata) Fed Extreme Diets Low in Fish Meal and Fish OilUse of butyrate or glutamine in enema solution reduces inflammation and fibrosis in experimental diversion colitis.Propionate Ameliorates Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Reducing Inflammation and Oxidative Stress.The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition.Regulation of inflammation by short chain fatty acids.Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease.The role of probiotics and prebiotics in inducing gut immunity.Mucosal healing in inflammatory bowel diseases: is there a place for nutritional supplementation?Microbiome and metabolome data integration provides insight into health and disease.Role of short-chain fatty acids in colonic inflammation, carcinogenesis, and mucosal protection and healing.Gut Microbiota of Nonalcoholic Fatty Liver Disease.Dietary fibre-based SCFA mixtures promote both protection and repair of intestinal epithelial barrier function in a Caco-2 cell model.The S-layer Associated Serine Protease Homolog PrtX Impacts Cell Surface-Mediated Microbe-Host Interactions of Lactobacillus acidophilus NCFM.Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model.Interleukin-12 (IL-12)/IL-10 ratio as a marker of disease severity in Crimean-Congo hemorrhagic fever.EVALUATION OF ENEMAS CONTAINING SUCRALFATE IN TISSUE CONTENT OF MUC-2 PROTEIN IN EXPERIMENTAL MODEL OF DIVERSION COLITIS.Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphate-induced colitis: differential regulation of tumour necrosis factor-α and interleukin-18 in BALB/c and severe combined immunodeficiency mice.Determinants of Reduced Genetic Capacity for Butyrate Synthesis by the Gut Microbiome in Crohn's Disease and Ulcerative Colitis.An orally administered butyrate-releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium-induced murine colitis.The role of the microbiome for human health: from basic science to clinical applications.Immune regulation by microbiome metabolites.Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends.
P2860
Q26777641-AC3C89BF-9DB7-425D-9A46-2DFA8F137B37Q26782801-50DFB2EA-BEFC-40D3-A3CD-75F9DEA9C153Q26796616-A8FBC20A-95BB-4B49-8B56-061769B40FA7Q28084903-7B902CB2-725A-4667-B589-082C55C5A2CDQ33470938-07752DA0-BA01-4684-BD1E-8AB2952F8E5FQ34361155-E26FFDAC-01DB-4F96-9E3E-7293D9BD3FE2Q34625951-3ACACAE5-1F13-4495-99BB-C613304859A2Q34636181-1F4535EC-5C91-47EC-A2F9-17E7BC79FF07Q34827374-BC965D6A-F1FF-4999-A2A6-C9D850D63ABCQ35027853-7DBC7CDB-9634-41CA-8145-BB3E6BD65E99Q35049771-6CA93D39-3113-4C26-BB50-9C0C57CBEB69Q35105259-0658FD48-0526-49C2-A494-084C1E6A3F8DQ35164201-857C886A-446C-4A71-9759-B920685B9EA1Q35170633-9AFA8D9D-1576-41BB-9E32-F368A4353F6DQ35328232-B7855FDA-C59D-48D6-8023-606E9B3F8451Q35535967-2CB4671D-820A-4264-8FCC-D08B173006F6Q35625435-E63711DE-7FDE-418D-A221-85140358B104Q35682224-37D834B5-9EB2-47ED-BF80-AB644C9A3AC8Q36206724-89CC013D-F986-4713-BD12-A92C14DB236CQ36215483-0DC69563-F103-4EBD-86FD-7AE5CC2CF22AQ37172417-C5FD8D62-3935-43F7-B859-3AD890F5D65FQ37587618-70506B9B-4B11-4177-965E-64FD214F2DF0Q37976701-3F937337-BF38-4942-AADC-467DAD0C22ACQ38029111-2CEC8379-5D88-4D5D-847B-3BEDB948AA2BQ38174603-209D441E-63AB-4B34-8BDE-387ADA7FD889Q38248111-F88D2484-6FF5-4132-97AF-74BE09854C66Q38648247-4787F338-92F1-4250-86B5-D74E4AC17482Q38731353-541CED79-FEC8-434B-A58C-E7B3DFD07B37Q38742769-0EE90105-5A5A-4F17-8E99-72DB6899CBB0Q40340991-942C83AA-FE5B-451B-8F37-04FD6E4E5297Q40995884-B3AF1B2E-B21A-4ECF-867E-B364FD8702A1Q41050086-FC641724-8E72-413E-B27C-70D9511A823FQ43157692-9E19E57A-29A0-466C-9438-44F2A4FEC490Q47110495-BF8823DD-54E8-40C0-998A-DFD41628812DQ48761759-050990FD-458A-4BDE-99CD-B2BB332E70BCQ49650701-D27CA62A-1094-447F-8ABD-0FBC62914FCFQ51450186-A01B30B2-AFC8-46FB-BF9C-4232F421D6D1Q54214888-EE0B7EB5-A0F2-4EA4-96A3-BE1DC70DB6DDQ54250172-75F30995-AB9F-47C2-AB9F-564559FA00DCQ55506746-D2D774CC-6DB4-4064-96AD-374416165303
P2860
Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of butyrate enemas on i ...... cerative colitis in remission.
@en
Effect of butyrate enemas on i ...... cerative colitis in remission.
@nl
type
label
Effect of butyrate enemas on i ...... cerative colitis in remission.
@en
Effect of butyrate enemas on i ...... cerative colitis in remission.
@nl
prefLabel
Effect of butyrate enemas on i ...... cerative colitis in remission.
@en
Effect of butyrate enemas on i ...... cerative colitis in remission.
@nl
P2093
P1433
P1476
Effect of butyrate enemas on i ...... lcerative colitis in remission
@en
P2093
Adriaan de Bruïne
Daisy M A E Jonkers
Freddy J Troost
Ger Rijkers
Henrike M Hamer
Koen Venema
Steven A L W Vanhoutvin
P304
P356
10.1016/J.CLNU.2010.04.002
P577
2010-05-15T00:00:00Z